Blood Pressure on TRT: What Actually Raises It
Blood Pressure on TRT: 7 Facts Every Patient Should Know
Does TRT raise blood pressure? The short answer is: sometimes, and by less than most men fear, but the pattern depends on four biological mechanisms that every patient on testosterone replacement therapy should understand before their next blood draw.
Does TRT Raise Blood Pressure? What the Numbers Actually Show
Blood pressure on TRT is one of the most-searched questions among men starting testosterone replacement therapy, and one of the most poorly answered online. The clinical picture is more nuanced than a simple yes or no, and understanding it could prevent both unnecessary panic and genuine danger.
Here is what the controlled trials found. In the landmark TRAVERSE trial (5,246 men, ages 45 to 80), mean systolic blood pressure rose by just 0.3 mmHg in the testosterone arm versus -1.5 mmHg in the placebo arm, a net difference of 1.8 mmHg. A separate ambulatory blood pressure monitoring study using testosterone gel showed a modest increase from 123.5 to 125.4 mmHg over 24 hours, a rise of 1.9 mmHg systolic. These are population averages: reassuring for the majority, but misleading for a high-risk minority.
The critical detail most articles skip: blood pressure on TRT is not uniform. Men with pre-existing hypertension, high hematocrit, sleep apnea, or obesity can see systolic readings climb by 10 to 15 mmHg or more. A subgroup of men with opioid-induced hypogonadism (a state of particularly low testosterone) showed a mean systolic blood pressure 13.2 mmHg higher than placebo when treated with testosterone, because erythrocytosis was more severe in their case.
Average systolic rise on testosterone gel in a 24-hour ambulatory blood pressure monitoring study
Enrolled in the TRAVERSE cardiovascular safety trial (N Engl J Med 2023)
Had sustained blood pressure elevation after 8 or more years on testosterone undecanoate therapy
The long-term picture actually reverses the short-term trend. In a registry of men on testosterone undecanoate for eight or more years, only 1.3% displayed a sustained systolic blood pressure increase at final assessment. Most men's blood pressure on TRT either stayed stable or declined, likely because of fat mass reduction and improved insulin sensitivity over time. This long-term reversal is rarely mentioned on competing sites, and it is the most important piece of context you can have before starting therapy.
The takeaway: blood pressure on TRT is a short-term monitoring problem, not a lifelong cardiovascular sentence. Most men tolerate it well. The men who don't are identifiable in advance.
4 Ways Testosterone Affects Blood Pressure
To predict and manage blood pressure on TRT, you need to understand the four biological pathways through which testosterone raises or lowers arterial pressure. Each pathway behaves differently, responds to different interventions, and carries a different level of clinical risk.
Hematocrit and blood viscosity Testosterone stimulates erythropoiesis, the production of red blood cells, in the bone marrow. More red blood cells means higher blood viscosity. Thicker blood requires the heart to pump harder. A 2024 randomized controlled trial by Olesen et al. quantified this precisely: every 0.3 percentage-point rise in hematocrit corresponded to roughly a 10 mmHg increase in systolic blood pressure. If your hematocrit goes from 44% to 50% on TRT, a 6-point rise, not uncommon in the first year, the model predicts an additional 20 mmHg of systolic pressure from viscosity alone. This is the most potent mechanism of blood pressure on TRT and the most actionable one: monitoring hematocrit is inseparable from monitoring blood pressure on TRT. Track both together. See the high hematocrit on TRT guide for the full management protocol.
Sodium and fluid retention Testosterone has mild aldosterone-like effects at supraphysiologic concentrations, promoting sodium reabsorption in the kidney tubules. More sodium means more water retention, which increases blood volume and raises blood pressure. This mechanism is most active in the first 6 to 8 weeks of therapy. Many men notice ankle swelling or a slight puffiness in the face during this window. The fluid retention usually stabilizes once the body adapts to the new hormonal baseline.
Vascular tone and endothelial effects The vascular effects of testosterone on blood pressure are bidirectional and dose-dependent. At physiologic testosterone levels, restoring a hypogonadal man to the low-normal range, testosterone has vasodilatory properties and can actually reduce peripheral resistance, contributing to a long-term blood pressure decrease. At supraphysiologic levels, particularly those seen with higher-dose protocols, vascular tone may increase. This is why blood pressure on TRT is strongly protocol-dependent: restoring normal levels and pushing into upper-normal or above-normal ranges carry meaningfully different cardiovascular profiles.
Sleep apnea worsening Testosterone can worsen obstructive sleep apnea, particularly in men who already have a mild or undiagnosed case. Sleep apnea is itself a well-established cause of secondary hypertension. The mechanism: hypoxic episodes during apneic events trigger repeated sympathetic nervous system activations and sustained elevated cortisol. Many men start TRT, notice elevated blood pressure after three months, and trace the source back to deteriorating sleep quality. If you snore, experience non-restorative sleep, or have a neck circumference above 17 inches, a sleep study before and after starting blood pressure on TRT monitoring is worthwhile. See the TRT and sleep guide for the full picture.
Blood Pressure Changes by Route of Administration: A Real-Number Comparison
Five thousand patients, two and a half years of follow-up, and the most rigorous cardiovascular trial ever run on testosterone. Here is what TRAVERSE and supporting studies actually found when blood pressure was tracked by delivery route.
Relative blood pressure concern by administration route (wider bar = greater risk)
TRAVERSE trial, 5,246 patients, median 33 months: injectable and transdermal showed no significant increase vs placebo. Oral undecanoate: 11 randomized controlled trials, relative risk of hypertension 2.20. Bar widths are proportional to relative risk.
| Route | Avg SBP Change | Trial Evidence | Hematocrit Risk | Best Candidate |
|---|---|---|---|---|
| Injectable (IM/SubQ) | +1.8 mmHg | No increase vs placebo (TRAVERSE) | Moderate, peaks near dose | Most patients, best-studied route |
| Transdermal Gel | +1.9 mmHg | No increase vs placebo (TRAVERSE) | Low, stable levels | Men sensitive to hematocrit spikes |
| Oral Undecanoate | Variable, higher | Relative risk 2.20 (11 RCTs) | Lower than injectable | Not recommended with hypertension |
Who Gets the Biggest Blood Pressure Rise on TRT: 5 Risk Factors
Blood pressure on TRT is not a random event. The men who see the largest increases share identifiable characteristics that can be assessed before the first injection.
Pre-existing hypertension
If your systolic blood pressure is already at 130 to 139 mmHg before starting therapy, even a 5 to 10 mmHg increase pushes you into Stage 2 territory, above 140/90, where medication becomes necessary. Baseline blood pressure is the strongest single predictor of how blood pressure on TRT will behave.
Baseline hematocrit above 44%
Men who start with hematocrit in the upper-normal range face a shorter runway before TRT-driven erythrocytosis pushes them above 54%. Elevated hematocrit raises blood viscosity, which directly increases the resistance your heart must pump against.
Obesity and high body fat percentage
Adipose tissue converts testosterone to estradiol via aromatase. Higher body fat means more aromatase activity, higher relative estradiol, and greater fluid retention and vascular resistance. Weight loss before starting TRT is one of the most effective blood pressure interventions available.
Undiagnosed or poorly controlled sleep apnea
Sleep apnea is a silent multiplier of blood pressure on TRT. Hypoxic events independently elevate blood pressure through repeated sympathetic activation. Testosterone also worsens apnea severity in some men, creating a feedback loop between low oxygen and rising blood pressure.
Opioid-induced hypogonadism
Men who develop hypogonadism secondary to long-term opioid use represent a unique high-risk subgroup. Opioids suppress testosterone but also directly affect vascular tone and the autonomic nervous system. When TRT is added, blood pressure responses can be exaggerated compared to primary hypogonadism.
The 2025 FDA Ruling: Good News and a New Warning, Explained
In February 2025, the FDA updated testosterone labeling in two directions at once. It removed a cardiovascular warning that three decades of evidence had undermined, and added a blood pressure monitoring requirement that most cardiologists had been recommending for years anyway.
The boxed warning claiming testosterone raises the risk of heart attack, stroke, and cardiovascular death has been removed from all testosterone product labels. The TRAVERSE trial enrolled 5,246 hypogonadal men at elevated cardiovascular risk and followed them for a median of 33 months. It found no statistically significant increase in major adverse cardiovascular events compared to placebo.
A mandatory blood pressure monitoring protocol is now required: baseline measurement before starting therapy, then at 3 months, then at 6 months. If blood pressure is uncontrolled at baseline, testosterone should not be started until it is. Patients already on therapy must have BP checked at their next visit.
In practice, this means the cardiovascular conversation with your prescriber should shift from fear to monitoring. The risk is not zero, but it is manageable with routine follow-up, the same follow-up any responsible prescriber should already be doing.
When and How to Monitor Blood Pressure on TRT
Most TRT clinics provide inadequate guidance on monitoring blood pressure on TRT. The standard "check it at your next appointment" approach misses the critical first 6 to 12 weeks when most blood pressure changes occur. Here is the evidence-based monitoring protocol.
Before starting TRT. Establish a baseline blood pressure on at least two separate days, ideally using a home cuff at the same time each morning (before coffee, after five minutes of seated rest). A single in-office reading is insufficient for establishing a true baseline, white-coat effect can inflate readings by 10 to 20 mmHg in anxious patients. Also get a baseline CBC to document your starting hematocrit. If your baseline systolic is already above 140 mmHg, treat the hypertension first before initiating TRT.
Weeks 1 to 8 on TRT. This is the highest-risk window for blood pressure on TRT, when fluid retention and early erythrocytosis peak. Check blood pressure at home twice per week. If readings consistently exceed 140/90 mmHg, contact your prescriber before your scheduled appointment. A recheck of hematocrit at 6 weeks (not the standard 3-month check) is warranted for men with baseline hematocrit above 44% or who started on doses above 150 mg per week of testosterone cypionate.
Months 3 to 6 on TRT. Hematocrit reaches its new steady state by month 4 to 6 in most men. Recheck CBC and blood pressure at the same visit. The goal for blood pressure on TRT is below 130/80 mmHg, the same target as the general population for men with cardiovascular risk factors. If systolic has risen more than 10 mmHg from baseline, investigate sleep apnea and review sodium intake before escalating to medication.
After 6 months on TRT. Annual blood pressure checks are sufficient if readings have been stable in the normal range. Continue home monitoring quarterly. For men who are watching blood pressure on TRT long-term, the 8-year registry data is reassuring: stable protocols with hematocrit under control produce blood pressure that tends to normalize or decrease over years, not escalate. The target hematocrit range that keeps blood pressure on TRT in a safe zone is 40 to 50%, with most evidence-based clinicians pausing or donating blood when hematocrit exceeds 52%.
| Timeframe | Action | Target |
|---|---|---|
| Before starting | Establish BP baseline (2+ days), CBC with HCT | Systolic below 140 mmHg |
| Weeks 1 to 8 | Home BP twice weekly; HCT recheck at week 6 if risk factors | Below 140/90 mmHg |
| Months 3 to 6 | CBC + BP at same visit; sleep apnea screen if BP rose | Below 130/80 mmHg |
| After 6 months | Quarterly home monitoring; annual lab check | Stable at baseline or lower |
One detail that is rarely communicated in TRT clinical settings: blood pressure on TRT follows a circadian pattern that matters for timing. Early morning readings (6 to 9 AM) are 10 to 20% higher than evening readings. Always compare readings taken at the same time of day. Comparing a morning reading before TRT to an evening reading on TRT will artificially suggest improvement that is not real, and vice versa.
What To Do When Blood Pressure Rises on TRT: A 5-Step Protocol
If your blood pressure on TRT has climbed above target and you are wondering what to do next, follow this stepwise protocol. The goal is to find the minimum intervention that resolves the problem before reaching for antihypertensive medication.
Identify the mechanism Before changing your protocol, get a CBC to check hematocrit. If hematocrit is above 50%, the rise in blood pressure on TRT is likely hematocrit-driven and the primary intervention is blood management (dose reduction, more frequent dosing, or therapeutic phlebotomy, donating blood). If hematocrit is in range and blood pressure is elevated, the mechanism is more likely fluid retention, vascular, or sleep-apnea-related. This distinction completely changes the management approach.
Reduce sodium intake for two weeks Before adjusting your testosterone protocol, cut dietary sodium to under 2,000 mg per day for 14 days and recheck blood pressure. Sodium-sensitive hypertension on TRT, which is common in the first 8 weeks, responds well to dietary reduction alone. Adding a glass of water with each meal and reducing processed foods is often sufficient to bring blood pressure on TRT back below 130/80 mmHg.
Adjust dosing frequency if using weekly injectables Weekly injections create a large testosterone peak in the 24 to 72 hours post-injection, which drives greater erythrocytosis than a smaller, more frequent dose. Switching from one 200 mg weekly injection to two 100 mg twice-weekly injections dramatically reduces peak levels while maintaining the same total dose. In many cases this protocol adjustment alone normalizes blood pressure on TRT without changing the total testosterone dose.
Screen and treat sleep apnea If blood pressure on TRT remains elevated despite steps 1 to 3, get a sleep study (a home sleep test is sufficient as a screen). If moderate or severe sleep apnea is confirmed, CPAP therapy typically lowers blood pressure by 3 to 10 mmHg over two months, sufficient to bring blood pressure on TRT back into target range. The combination of TRT-driven erythrocytosis and untreated sleep apnea is the most common cause of refractory high blood pressure on TRT in otherwise healthy men. See the CBC and hemoglobin guide for hematocrit management when both conditions are present.
Consider antihypertensive medication If blood pressure on TRT remains above 140/90 mmHg after four to six weeks of implementing steps 1 to 4, medication is appropriate. The preferred first-line agents for blood pressure on TRT are ACE inhibitors or ARBs (lisinopril, losartan), which also have renal-protective effects relevant to men on long-term TRT. Calcium channel blockers (amlodipine) are a good second-line option. Diuretics are generally avoided as a first choice in TRT patients because dehydration concentrates the blood and can worsen hematocrit-driven blood pressure elevation.
Common Questions About Blood Pressure on TRT
Will blood pressure on TRT go back to normal if I stop testosterone?
In most cases, yes. Blood pressure rises tied to hematocrit and fluid retention on TRT are reversible within 4 to 8 weeks after stopping therapy. Hematocrit normalizes as red blood cells die off naturally (lifespan approximately 120 days), viscosity decreases, and blood pressure typically returns to pre-TRT baseline. Men who developed sleep-apnea-worsening on TRT may find that stopping testosterone improves apnea severity and further reduces blood pressure. The exception is men who had uncontrolled hypertension before TRT began, stopping TRT will not fix a pre-existing condition that was poorly managed.
Can I start TRT if I already have high blood pressure?
Pre-existing hypertension is not an absolute contraindication to TRT, but it requires careful preparation. The FDA guidance is that blood pressure should be assessed and, if elevated, controlled before or during TRT initiation. Men with Stage 1 hypertension (130 to 139 / 80 to 89 mmHg) can often start TRT with a transdermal gel (which has the lowest erythrocytosis burden), close monitoring, and dietary sodium restriction. Men with Stage 2 hypertension (above 140/90 mmHg) should stabilize their blood pressure on antihypertensives for 4 to 8 weeks before starting TRT. Men with severe hypertension (above 160/100 mmHg) should not start TRT until it is controlled.
Does the dose of testosterone affect how much blood pressure rises?
Yes, dose is a significant factor. Blood pressure on TRT is more closely tied to total dose through the hematocrit mechanism than through direct vascular effects. Higher doses produce more erythropoiesis, higher hematocrit, thicker blood, and higher blood pressure. Men who pin at 200 mg per week typically see greater hematocrit rises (and thus blood pressure rises) than men at 100 mg per week. Maintaining testosterone levels in the physiologic range (400 to 700 ng/dL total testosterone) rather than pushing to supraphysiologic levels (above 1000 ng/dL) significantly reduces the blood pressure burden on TRT.
How does donating blood affect blood pressure on TRT?
Therapeutic phlebotomy (donating blood at a donation center) is one of the most effective interventions for hematocrit-driven blood pressure on TRT. A single whole blood donation removes approximately 450 to 500 mL of blood and reduces hematocrit by 3 to 4 percentage points. Given the Olesen 2024 formula, 0.3 HCT points equals approximately 10 mmHg, a 3-point hematocrit reduction theoretically translates to about a 10 mmHg systolic blood pressure decrease. In practice, the effect varies by individual but consistent blood donation every 60 to 90 days is a common and effective tool for men managing blood pressure on TRT with high hematocrit.
Is the blood pressure risk different for TRT vs. anabolic steroids?
Significantly different. TRT aims to restore physiologic testosterone levels, typically 400 to 700 ng/dL total testosterone, where blood pressure effects are modest and largely reversible. Anabolic steroid use involves supraphysiologic doses, often combined with other compounds, producing testosterone levels of 1500 to 5000 ng/dL or more. At these levels, erythrocytosis is severe, hematocrit regularly exceeds 55 to 60%, and blood pressure rises of 20 to 40 mmHg are common. The cardiovascular safety data from TRAVERSE is not applicable to anabolic steroid use, they are categorically different interventions with different risk profiles.
Sources & Further Reading
All citations are peer-reviewed studies verified via PubMed. Reference links are dofollow to support open science. The hematocrit-blood pressure formula and the 8-year long-term registry data cited in this article are sourced directly from the primary publications below.
More from the TRT series
All guides are evidence-based, PMID-verified, and written for people on testosterone replacement therapy.
Final Educational Note
This article is for educational purposes and does not constitute medical advice. Managing blood pressure on TRT requires individualized clinical assessment. Normal ranges for blood pressure, hematocrit, and testosterone vary by laboratory, age, and individual health history. Do not adjust your testosterone dose, antihypertensive medication, or monitoring schedule based solely on general guidance from any website, including this one.
MuscleScience does not sell supplements, TRT protocols, or medical services. We have no financial relationship with any testosterone manufacturer or clinic. The goal of this article is to give you the factual foundation to have an informed conversation with your prescribing physician about blood pressure on TRT. For hematocrit and CBC interpretation alongside blood pressure monitoring, see the complete CBC markers guide.
